Bank of America and Credit Suisse First Boston's credit for dialysis provider, DaVita Inc., will be shown to investors today in Los Angeles and on Friday in New York to a buyside eager to jump in on the huge $800 million "B" piece. "They're bumping up the leverage, but they generate so much cash flow and they plan to continue to pay down debt," said one buysider who is looking to invest in the seven-year term loan "B" at pricing of LIBOR plus 3 1/4%. Rich Whitney, cfo at DaVita, is otptimistic that interest in the name will generate enough orders to potentially result in a reverse flex on the deal. "There's a good chance they'll be a flex down," he said, regarding positive buzz on the credit.
March 20, 2002